5th Workshop on Dendritic Cell Biology: Anti-tumoral immunotherapy, from biology to the clinic

Registrations are now open for the 5th Workshop on Dendritic Cell Biology: Anti-tumoral immunotherapy, from biology to the clinic, which will take place in Lisbon at the Champalimaud Foundation, the 27-29 March, 2019. This event is co-organised by Champalimaud Foundation (Lisbon) and Institut Curie (Paris).

This fifth LABEX DCBIOL workshop will focus on “Anti-tumor Immunotherapy”. Immunotherapy is about to revolutionize cancer treatment. It consists in treating cancer by stimulating the immune system so it can efficiently attack tumor cells. The aim of this course is a better understanding of how the immune system actors including dendritic cells detect and fight tumor cells and how their activities can be boosted. It will include talks on the clinical applications of immunotherapy in cancer treatments.  Speakers will include internationally renowned scientists and physicians in the field that will provide a general overview of the basic, translational, and clinical research in the field.

This course is free and open to all the members of the DCBIOL Labex community (Institut Curie, Paris et CIML, Marseille) and to scientists and physicians working in the field (subscription of young scientists and physicians will be privileged).

Register now: http://sondage.curie.fr/index.php?sid=68886&lang=en